Nebulized inhalation of Mycobacterium vaccae vaccine or shortens the time for the new crown nucleic acid to turn negative

Science and Technology Daily, Nanning, April 5th (Reporter Liu Hao) On the 5th, the reporter learned from Guangxi Medical University that the team of Professor Li Chaoqian of the school carried out "Aerosolized Inhalation of Mycobacterium vaccae Vaccine in the Treatment of COVID-19 Clinical Study-A Randomized Study" The "double-blind controlled experiment" study showed that the technology can shorten the time for nucleic acid to become negative, and there is no severe disease, reyang and obvious adverse reactions.

Severe Acute Respiratory Syndrome Type 2 Coronavirus is highly contagious, and there is currently no specific treatment.

According to the research team members, the selected cases were randomly divided into 2 groups: group A (conventional treatment group) and group B (mycobacterium vaccae vaccine combined with conventional treatment group).

Professor Li Chaoqian’s team has been engaged in respiratory mucosal immunity research for many years.

"The team's series of basic, animal and clinical research results show that the new technology and theoretical research results are expected to provide new ways and theoretical basis for clinical non-specific early prevention and treatment of respiratory virus infections.